ArticlePloS one2022

Promising FDA-approved drugs with efflux pump inhibitory activities against clinical isolates of Staphylococcus aureus.

Safaa Abdel-Aal Mohamed Abdel-Karim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.